Announcements

3 November 2025
Welcoming New Early Career Editorial Board Members of Pharmaceuticals


Pharmaceuticals (ISSN: 1424-8247) is pleased to announce that the following 30 researchers have been added to our group of 2025–2026 Early Career Editorial Board Members (ECEBMs). Applications for the Early Career Editorial Board are now closed. Please join us in congratulating them on joining the Pharmaceuticals community!

Name

Affiliation

Interests

Guang Huang

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA

medicinal chemistry; drug design and discovery; chemical biology

Aldo Sena de Oliveira

Gulbenkian Institute for Molecular Medicine (GIMM), Faculty of Medicine, University of Lisbon, 1649-028 Lisbon, Portugal

medicinal chemistry; IA; molecular docking; QSAR; molecular dynamics; ADMET

Junhuang Jiang

Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA

AI-driven drug formulation and development

Paolo Governa 

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy

drug discovery; drug design; computer-aided drug design; natural products; molecular modeling; pharmaceutical sciences

Giulia Bononi

Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy

medicinal chemistry; small-molecule drug design; organic synthesis; cancer; cancer cell metabolism; anti-cancer drugs; enzymatic assays; biological evaluation; structure–activity relationship (SAR)

Pura Ballester

Faculty of Pharmacy and Nutrition, Universidad Católica de Murcia (UCAM), campus los Jerónimos 177, Murcia, Spain

pharmacology; autism; sleep problems; clinical trials; biomolecules; medication errors; medication adherence

Ju-Seop Kang

Department of Pharmacology & Clinical Pharmacology Laboratory, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea

drug delivery systems; clinical pharmacology; pharmacokinetics; disease models; new drug development; clinical trials; exosome; clinical toxicology; therapeutic drug monitoring; drug assay methods; development in biological fluids

Ilaria D'Agostino

Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy

chemical modification of natural compounds; medicinal chemistry; food chemistry; antioxidants; antimicrobials; anti-inflammatory compounds; anticancer compounds; guanidines; organic synthesis; delivery systems; drug resistance

Alessandro Giraudo

Dipartimento di Scienze Farmaceutiche Università degli Studi di Milano, Milan, Italy

drug discovery; medicinal chemistry; nicotinic acetylcholine receptors; cystic fibrosis; GABA receptors; anti-malarial agents

Ziran Li

UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), University of California San Francisco, 600 16th St., San Francisco, CA 94158, USA

pharmacokinetics and pharmacodynamics modeling; machine learning; clinical pharmacology; pharmacometrics

Na Ye

Department of Medicinal Chemistry, Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China

drug targets; medicinal chemistry; CNS disorders; cancer; small molecules; design and synthesis

Guodong Yao

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China

natural product chemistry

Yinjia Cheng

School of Chemistry and Materials Science, South-Central University for Nationalities, Wuhan 430074, China

medical therapeutic nanomaterials

Jiamin Wu

Institute for NanoBioTechnology, Whiting School of Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA

drug delivery; biologics

Fei Xie

Department of Organic Chemistry, School of Pharmacy, Naval Medical University, Shanghai, China

synthetic organic and medicinal chemistry; drug discovery, drug design, and development, mainly in antifungal compound (azoles, triazines, aminonicotinamides, etc.), and biological evaluation; computer-aided drug design; ADME properties and structure-activity relationship studies; organic chemistry teaching and graduate education

Wang Ning

Institute for Tissue Engineering and Regenerative Medicine, Chinese University of Hong Kong, Hong Kong

the regulation and application strategies for bone pathology and regeneration in type 2 diabetes mellitus; pharmacology and treatment for osteoporosis

Darpan Raghav

Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA

drug discovery; cancer research; medicinal chemistry; protein biochemistry and biophysics; molecular dynamics simulations; molecular modeling; structure biology

Xianyan Qin

School of Medicine, University of Electronic Science and Technology of China (UESTC), Chengdu, China

novel targeted nanocarriers

Yuanzhi Chen

School of Public Health, Xiamen University, Xiamen, China

nanoparticles and oleylamine

Marko Antonijevic

Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia

molecular docking; molecular dynamics; computational chemistry; DFT; antioxidants; anticancer compounds

Xuechun Wang

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY 11439, USA

inhalation; formulation development; nanoparticles; microparticles; lipid nanoparticles; pulmonary drug delivery; plga; amorphous solid dispersion; oral solids; extended release; HPMC; small molecules; lung cancer; respiratory diseases; pulmonary fibrosis

Tailong Lei

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China

molecular mechanisms of drug resistance and virulence in clinical microorganisms; computer-aided drug discovery; computational toxicology; cheminformatics

Yibin Yu

Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Nanjing, China

drug delivery

Sunil Gaikwad

Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia

medicinal chemistry; organic chemistry; heterocyclic chemistry; drug discovery; molecular docking

Santo Previti

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy

trypanosoma brucei; antitrypanosomal agents

Adriana Molina

Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal

cucurbita maxima duchesne; natural food preservatives; process optimization; phenolic compounds; pumpkin peel; bioactivity; rsm

Mikel Añibarro-Ortega

Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal

heat-/ultrasound-assisted extraction; process optimization; antioxidant/antimicrobial activity; phenolic compounds; organic acids; tocopherols; bioactivities; nutritional value

Ana Iglesias-Mejuto

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, I+D Farma Group (GI-1645), Faculty of Pharmacy, Health Research Institute of Santiago de Compostela (IDIS), Agrupación Estratégica de Materiales (AeMAT), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain

biopolymers; aerogels; scaffolds; 3D printing; nanotechnology; tissue engineering

Domiziana Masci

Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito, 1, 00168 Rome, Italy

medicinal chemistry; synthetic medicinal chemistry; heterocyclic chemistry

Pharmaceuticals Editorial Office

More News...
Back to TopTop